yeah I'm just trying to bring some dots together.
EU EFS on the FDA website??
EU EFS that includes both original and ViV??
Additional Bench and animal testing??
Anyone got a clue how it ties together and the path forward?
Money is a concern but im guessing that is why they are trying to get on the NASDAQ but as we will be dual listed are we still constrained by the 7.1 ASX rule?
- Forums
- ASX - By Stock
- AVR
- Clinical trials
Clinical trials, page-11
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$14.00 |
Change
0.800(6.06%) |
Mkt cap ! $295.9M |
Open | High | Low | Value | Volume |
$13.08 | $14.00 | $12.84 | $202.5K | 15.04K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 88 | $13.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.00 | 1109 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 88 | 13.200 |
1 | 200 | 13.020 |
1 | 200 | 13.000 |
1 | 50 | 12.990 |
1 | 500 | 12.860 |
Price($) | Vol. | No. |
---|---|---|
14.000 | 1109 | 2 |
14.420 | 500 | 1 |
14.500 | 1000 | 1 |
14.750 | 250 | 1 |
15.500 | 370 | 1 |
Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |